Luxist Web Search

Search results

1. Results From The WOW.Com Content Network

2. Eli Lilly and Company - Wikipedia

   en.wikipedia.org/wiki/Eli_Lilly_and_Company

   Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.

3. Weight-loss drug drives Eli Lilly to raise 2024 sales ... - AOL

   www.aol.com/news/eli-lilly-lifts-profit-view...

   Eli Lilly raised both ends of its 2024 revenue forecast by $2 billion and now expects $42.4 billion to $43.6 billion for the year. The drugmaker also raised its annual profit forecast by $1.30 per ...

4. Atomoxetine - Wikipedia

   en.wikipedia.org/wiki/Atomoxetine

   Atomoxetine is a selective norepinephrine reuptake inhibitor and is believed to work by increasing norepinephrine and dopamine levels in the brain. [12] [10] The effectiveness of atomoxetine is comparable to the commonly prescribed stimulant medication methylphenidate .

5. These Are the Hottest Careers for Entry-Level Workers - AOL

   www.aol.com/hottest-careers-entry-level-workers...

   Remote work options rank a close second behind salary when it comes to what entry-level jobseekers consider as they graduate college and prepare to enter the workforce, according to a new survey ...

6. Lilly Endowment - Wikipedia

   en.wikipedia.org/wiki/Lilly_Endowment

   Lilly Endowment Inc., headquartered in Indianapolis, Indiana, is one of the world's largest private philanthropic foundations and among the largest endowments in the United States. It was founded in 1937 by Josiah K. (J. K.) Lilly Sr. and his sons, Eli Jr. and Josiah Jr. (Joe), with an initial gift of Eli Lilly and Company stock valued at ...

7. Eli Lilly: Positive results on its new Alzheimer's drug

   www.aol.com/finance/eli-lilly-positive-results...

   Eli Lilly stock closed up 6.68% to $431.19 on Wednesday. There is, however, some concern among experts. Two patients died from the drug, and a third died during the clinical trials, the company said.